Pain Therapeutics, Inc. (NASDAQ:PTIE) Announces Updates to Portfolio With Respect to REMOXY

Pain Therapeutics, Inc. (NASDAQ:PTIE) has been making quite a few updates to its drug portfolio. The company announced that it would be resuming the control of REMOXY, after reaching an agreement with Pfizer Inc. (NYSE:PFE). Additionally, the company has also been conducting research on how it can use the drug to lower human abuse potential. […]